Orthopedic device company Sacrix launched the third iteration of SacroFuse, a threaded compression device designed for immediate stabilization of the sacroiliac joint.
The new design is a screw-cage hybrid intended to facilitate insertion and osseointegration, according to a Jan. 23 news release. The device is self-drilling, self-tapping and compresses across the sacroiliac joint.
Sacrix added more graft space, while maintaining the product's biomechanical and pull-out strength. An orthopedic spine surgeon developed the device with input from pain management and interventional physicians.
The company said it has performed more than 20 labs in 2020 and five labs so far in 2021.
Sacrix is a portfolio company of KICVentures Group, which acquired NanoFuse Biologics in December.